Haploidentical Bone Marrow Transplant for Sickle Cell Disease
Two-year event-free survival comparable to matched sibling donor myeloablative transplant
Two-year event-free survival comparable to matched sibling donor myeloablative transplant
First-in-human trials of CRISPR/CASP 12 gene editing demonstrate safety and meaningful event-free survival
Explore special articles published online first to coincide with presentations at ATS American Thoracic Society International Conference.
Skin cancer is the most common cancer in the U.S. and we need all the protection we can get. So why is it so hard…
This cohort study of Korean women uses mammographic breast cancer screening data to assess the risk factors for interval breast cancer vs screen-detected breast cancer…
The Detroit-based health system is making sure that older adults with limited digital literacy or access also see telehealth’s benefits.
As the FDA observes Clinical Trials Day, we reflect on the progress made and the widespread efforts underway to advance clinical trial innovation.
Casting harm reduction programs for drug users as inherently opposed to order and public safety is a false choice, addiction experts said at #STATBreakthrough.
Join me tomorrow, Tuesday May 21st at Noon ET for a live Zoom webinar.
Nicola Jones says she was nine years old when she received a contaminated blood product in London.
The prevalence of testosterone deficiency varies from 12% to 39% across men in their 50s to 80s. Urologists offer insights into management and more.